Ich E2br3 Blog Category 503B(b)(2) 505(b)(1) 505(b)(2) 510(k) Abbreviated New Drug Application (ANDA) Absorption Distribution Metabolism Excretion(ADME) Accelerated Approval Active Pharmaceutical Ingredient (API) Advanced Therapy Medicinal Product (ATMP) Adverse Events (AE) Agency Alerts Analytical Instrument Qualification Analytical Method Transfer Checklist Analytical Methods Anderson- Darling Test Animal Health Annex 1 Artificial Intelligence (AI) Asia Audit Trail Audits Australia Autism Benchling Big Data Biologics License Application (BLA) Bioresearch Monitoring Program Information (BIMO) Biostatistics Biotech Startup Blog Canada Cell and Gene Therapy (CAGT/CGT) Center for Biologics Evaluation & Research (CBRE) Center for Drug Evaluation (CDE) Center for Drug Evaluation and Research (CDER) Chemistry, Manufacturing, and Controls (CMC) China Cleaning Validation Clinical Data Clinical Evaluation Report (CER) Clinical Research Clinical Research Solutions Clinical Study Report (CSR) Clinical Trial Concierge Services Clinical Trials Clinical Trials Disclosure (CTD) Clinical Trials Information System (CTIS) Clinical Trials Registration (CTR) CMO Compass Comm. for Medicinal Products for Human Use (CHMP) Commissioning Complete Response Letter (CRL) Compliance Compounding Pharmacy Computer Systems Validation (CSV) Conditional Marketing Authorisation (CMA) Confidence Interval Consent Decree Contact Centers Contract Development Manufacturing Org. (CDMO) Contract Manufacturing Organization (CMO) Contract Research Organization (CRO) Corrective and Preventive Actions (CAPA) COVID-19 CRISPR Current Good Manufacturing Practices (cGMP) DARWIN EU Data Integrity Data Standards Data Strategy De Novo Decentralized Clinical Trials (DCT) Deoxyribonucleic Acid (DNA) Design of Experiments (DOE) Digital Blueprint Digital Transformation Drug Approval Drug Development Drug Master File (DMF) Drug Supply Chain Security Act (DSCSA) electronic Common Technical Document (eCTD) Electronic Lab Notebook (ELN) Electronic Medical Record (EMR) Emergency Task Force (ETF) Environmental Monitoring EU Network for HTA (EUnetHTA) EU Pharmaceutical Legislation Reform EU-CTR EudraLex Volume 4 Europe European Medicines Agency (EMA) European Union (EU) Excipients Expanded Access Program (EAP) Failure Mode and Effects Analysis (FMEA) FDA 510(k) FDA Adverse Event Reporting System (FAERS) FDA Form 483 FDA Guidance FDA Meetings FDA News FDA Safety and Innovation Act (FDASIA) FDA Submission Final Guidance Fit for Purpose (FFP) Food & Drug Administration (FDA) Functional Service Provider (FSP) Gain of Function (GOF) General Regulatory Generally Recognized as Safe (GRAS) Generic Drug User Fee Amendments (GDUFA) Generic Drugs Generics Genetically Modified Organisms (GMO) GLP Good "x" Practice (GXP) Good Automated Manufacturing Practice (GAMP) Good Clinical Practice (GCP) Good Manufacturing Practice (GMP) Graduated Plan Officer (GPO) HDA Heads of Medicines Agencies (HMA) Health Insurance Portability & Accountability Act Health Technology Assessment (HTA) Humanitarian Device Exemption (HDE) Hunter's syndrome Hypothesis Test ICH E6 ICH GCP ICH M10 ICH Q3D Guideline Immunization In Vitro Diagnostic Regulation (IVDR) In Vitro Diagnostics (IVD) Individual Case Safety Report (ICSR) Innovative Licensing and Access Pathway (ILAP) Inspection Readiness Installation Qualification (IQ) International Council for Harmonisation (ICH) Intl Society for Pharmaceutical Engineering (ISPE) Intl. Coalition of Medicines Reg. Auth. (ICMRA) Investigational Medicinal Product (IMP) Investigational New Drug (IND) ISO 13485 Lab Developed Tests Labeling Laboratory Information Management System (LIMS) Life Science Consulting Local Person for Pharmacovigilance (LPPV) Lower Limit of Quantification (LLOQ) Manual of Policies and Procedures (MAPP) Manufacturing & Import Authorisation (MIA) License Market Access Marketing Authorization Holder (MAH) Medical Device Regulations (MDR) Medical Devices Medical Information Medical Monitoring Medical Writer (MW) Medicines & Healthcare Products Reg Agency (MHRA) Medicines Shortages Steering Group (MSSG) MedTech Meet the Expert Modernization of Cosmetics Regulation Act (MoCRA) Modified Vaccinia Virus Ankara (MVVA) Mpox National Competent Authority (NCA) National Drug Code (NDC) National Health Service (NHS) Natl Institute for Health & Care Excellence (NICE) New Drug Application News Nitrosamine North America Office of Generic Drugs (OGD) Office of Pharmaceutical Quality (OPQ) Office of Surveillance and Epidemiology (OSE) Oligonucleotides Oncology Operational Qualifications (OQ) Orphan Drug Act (ODA) Orphan Drug Designation (ODD) Out-of-Specification (OOS) P-value Paediatric Committee (PDCO) Patient Medication Information (PMI) Patient Support Programs (PSP) Patient Support Services (PSP) PDP (Prescription Drug Plan) Periodic Adverse Drug Experience Report (PADER) Periodic Benefit-Risk Evaluation Report (PBRER) Pharmacovigilance Pharmacovigilance Agreement (PVA) PIP PIPL PMA Policy 0070 Post-Approval Study Post-Marketing Pharmacovigilance Post-Merger Integration PQ Pre-Approval Inspection PRIME Privacy Process Optimization Process Validation Product Quality Complaints (PQC) Program & Project Management Promotional Review PSGs PSMF PSUR Psychedelics Qualification & Validation Qualified Person (QP) Qualified Person for Pharmacovigilance (QPPV) Quality & Compliance Quality Assurance Quality Control (QC) Quality Management System (QMS) Quality Management System Regulation (QMSR) Quality Management Systems Quality Risk Management (QRM) R&D Technology Rare Diseases Recruiting Regulatory Information Management Systems (RIMS) Regulatory Sciences Reporting Member State (RMS) Research Data Management Platforms Ribonucleic Acid (RNA) Risk Evaluation and Mitigation Strategy (REMS) Safety Data Safety Data Exchange Agreements (SDEA) Signal Management Single Safety Database Social Media Monitoring SOP Statistical Intervals Sterile Compounding Supplier Management Tariffs Technology Transfer The Joint Commission TPP United Kingdom (UK) United States Pharmacopeia (USP) Veeva Vendor Audits Wholesale Dealers Authorisation (WDA)